Sfoglia per Autore
Weekly 5-fluorouracil and folinic acid plus escalating doses of cisplatin with gluthatione protection in patients with advanced head and neck cancer
1992-01-01 Gebbia, V.; Valenza, R.; Testa, A.; Zerillo, G.; Restivo, S.; Cupido, G.; Ingria, F.; Spadafora, G.; Barbaccia, C.; Cannata, G.; Cipolla, C.; Gebbia, N.
Subcutaneous recombinant human erythropoietin prevents chemotherapy-related anemia in patients with advanced cancer.
1992-01-01 Gebbia, V; Gebbia, N; Testa, A; Valenza, R; Borsellino, N; Rausa, L; Agostara, B; Callari, A; Latteri, MA; Florena, M; Cipolla, C; Leto G
Levo folinic acid and 5-fluorouracil plus high dose epidoxorubicin as first line treatment for metastatic breast carcinoma
1993-01-01 Gebbia, V.; Testa, A.; Valenza, R.; Cipolla, C.; Amato, C.; Latteri, M.; Gebbia, N.; Florena, M.
Subcutaneous octreotide versus oral loperamide in the treatment of diarrhea following chemotherapy
1993-01-01 Gebbia, V.; Carreca, I.; Testa, A.; Valenza, R.; Curto, G.; Cannata, G.; Borsellino, N.; Latteri, M.; Cipolla, C.; Florena, M.; Gebbia, N.
A prospective evaluation of the activity of human granulocyte-colony stimulating factor on the prevention of chemotherapy-related neutropenia in patients with advanced carcinoma
1993-01-01 Gebbia, V.; Testa, A.; Valenza, R.; Borsellino, N.; Cipolla, C.; Cannata, G.; Curto, G.; Latteri, M.; Florena, M.; Gebbia, N.
Combination chemotherapy of 5-Fluorouracil, Epidoxorubicin and Mitomicin C in the palliative treatment of locally-advanced and/or metastatic adenocarcinoma of the stomach.
1994-01-01 Gebbia, V; Testa, A; Valenza, R; Latteri, MA; Bajardi, G; Mastrandrea, G; Cipolla, C; Pischedda, G; Curto, G; Cannata, G; Gebbia, N; Florena, M
A phase i-II study of cyclophosphamide, epidoxorubicin, levofolinic acid/5-fluorouracil and recombinant human granulocyte colony stimulating factor in metastatic breast carcinoma
1994-01-01 Callari A.; Gebbia V.; Testa A.; Cusimano M.P.; Cipolla C.; Amato C.; Cannata G.; Latteri M.A.; Garascia C.; Gebbia N.; Agostara B.
Ondasetron versus granisetron in the prevention of chemotherapy‐induced nausea and vomiting. Results of a prospective randomized trial
1994-01-01 Gebbia, V.; Cannata, G.; Testa, A.; Gurto, G.; Valenza, R.; Cipolla, C.; Lattri, M.; Gebbia, N.
Etoposide, doxorubicin (Adriamycin) and cisplatin regimen in advanced gastric adenocarcinoma: experience with a lower dose schedule
1994-01-01 Gebbia, V.; Valenza, R.; Testa, A.; Sciume, C.; Longo, A.; Cipolla, C.; Borsellino, N.; Leo, P.; Latteri, M.; Florena, M.; Gebbia, N.
ELF regimen in advanced gastrointestinal malignancies: An analysis of its clinical effectiveness and toxicity
1994-01-01 Gebbia, V.; Sciume, C.; Cannata, G.; Curto, G.; Valenza, R.; Testa, A.; Cipolla, C.; Cusumano, A.; Verderame, F.; Fortunato, S.; Di Gesu, G.; Leo, P.; Gebbia, N.
Weekly levofolinic acid and 5-fluorouracil plus hydroxyurea in metastatic gastrointestinal adenocarcinomas
1994-01-01 Gebbia, V.; Valenza, R.; Testa, A.; Cipolla, C.; Latteri, M.; Curto, G.; Comande, S.; Buccellato, C.; Gebbia, N.
Vinorelbine plus cisplatinum for the treatment of Stage IIIB and IV Non Small Cell Lung Carcinoma.
1994-01-01 Gebbia, V; Caruso, M; Valenza, R; Testa, A; Cannata, G; Verderame, F; Cipolla, C; Curto, G; Oliveri, D; Chiarenza, M; Latteri, MA; Di Gesù, G; Gebbia, N
Primary extranodal non-Hodgkin lymphomas of the uterus and the breast: report of three cases
1995-01-01 Latteri, M.; Cipolla, C.; Gebbia, V.; Lampasona, G.; Amato, C.; Gebbia, N.
Short term intensive preoperative chemotherapy with high doses of epirubicin plus G-CSF rescue for locally advanced Stage III breast carcinoma.
1996-01-01 Gebbia, V; Latteri, MA; Agostara, B; Valenza, R; Comandè, S; Callari, A; Blasi, L; Cipolla, C; Buccellato, C; Gebbia, N
Switching from morphine to methadone to improve analgesia and tolerability in cancer patients: A prospective study
2001-01-01 Mercadante, S.*; Casuccio, A.; Fulfaro, F.; Groff, L.; Boffi, R.; Villari, P.; Gebbia, V.; Ripamonti, C.
Opioid plasma concentration during switching from morphine to methadone: Preliminary data
2003-01-01 Mercadante, S.; Bianchi, M.; Villari, P.; Ferrera, P.; Casuccio, A.; Fulfaro, F.; Gebbia, V.
Mitoxantrone + Prednisone versus Taxotere + Prednisone nel trattamento del carcinoma prostatico ormonorefrattario (cpor ). Studio randomizzato di fase II del Gruppo Oncologico dell’Italia Meridionale (GOIM ). VII CONGRESSO NAZIONALE G.O.I.M. ROMA 23-25 Giugno 2004
2004-01-01 GIOTTA F; MANZIONE L; LORUSSO V; CARUSO M; FORTUNATO S; ROMANO R A; ROMITO S; GEBBIA V; VALERIO MR; DURINI E; BRUNETTI C; COLUCCI G
Activity and toxicity of oxaliplatin plus raltitrexed in 5-fluorouracil refractory metastatic colorectal adeno-carcinoma
2004-01-01 LAUDANI A; GEBBIA V; LEONARDI V; SAVIO G; BORSELLINO N; CUSIMANO MP; CALABRIA C; STEFANO R; AGOSTARA B
Chemotherapy for endometrial carcinoma
2005-01-01 GEBBIA V; AGUELI R
Non small cell lung cancer patients with ECOG PS2: unsolved questions and lessons from clinical trials
2005-01-01 GEBBIA V; GALETTA D; DE MARINIS F
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile